Class
Harnessing the power of fasting to fight aging and enhance health
10% of Americans now practice some form of intermittent fasting, but almost no products exist to support this massive market.

Mimio Health (fka Innate Biology) is a nutraceutical company dedicated to the research and production of the world’s first fasting mimetic supplement. Our supplement was designed from clinical research to replicate the cellular health benefits and lifespan-promoting effects of fasting without the need to fast.

Through years of research into human fasting we have uncovered a conserved metabolic program for cellular health and regeneration that underpins the beneficial effects of fasting. Our patent-pending fasting mimetic forumuation uses a rigorously selected combination of the same bioactive human metabolites that induce this regenerative “bio-program” to replicate the body’s natural response to fasting without having to fast. We have shown that our fasting mimetic is capable of extending the lifespan of model organisms by 96% and has powerful anti-inflammatory and antioxidant effects in human cells that could combat age-associated chronic inflammation and cellular damage allowing our customers to live longer, healthier lives.

Chris Rhodes, Ph.D., CEO
"We're giving you all the benefits of fasting—even when you eat."
Mimio Health has raised $500,000, from SOSV and Genesis Consortium
Mimio Health
Chris Rhodes, Ph.D., CEO
"We're giving you all the benefits of fasting—even when you eat."
Mimio Health has raised $500,000, from SOSV and Genesis Consortium
Climate relisilient crops for tomorrow, today
Half of all plant species are at risk from climate change.

Half of all plant species are at risk from climate change

The world is changing faster than crops can adapt. To make crops more adaptive, we need a speedier way to alter their gene expression. Most plant genes are unexplored because their role is too subtle to be picked up by GWAS. Avalo.ai are leaders in interpretable machine learning in the realm of agricultural genetics.

This drastically narrows (by around 100x) the scope of candidate genes to validate. Paired with a system to deliver gene regulators via the soil, Avalo.ai attempts to replace the trial-and-error breeding of the past with a computational and programmable responsive system.

Brendan Collins, CEO
"Today, new crop genetic development is a two-year process that takes $20 million. We want to make that four months, and $20 thousand."
Avalo.ai
Brendan Collins, CEO
"Today, new crop genetic development is a two-year process that takes $20 million. We want to make that four months, and $20 thousand."